Shares of early-stage biotech stocks, including Biohaven ( BHVN -6.50%), Recursion Pharmaceuticals ( RXRX -7.37%), and CRISPR Therapeutics ( CRSP 3.14%), plunged in March, with the stocks down 35.3%, ...

Climate change is rapidly altering the agricultural landscape, leaving farmers scrambling to adjust. As temperatures rise, ...

Recursion Pharmaceuticals uses artificial intelligence (AI) in its proprietary operating system to match new compounds ...

Scientists are studying how bacteria use CRISPR to defend themselves from phages ... coli infections and cholera, become ...

"These cells co-develop together, just like they would in an actual embryo, and establish that history of being neighbors," ...

A team of researchers at Karolinska Institutet has developed a novel tool for genetic research. The study, published in ...

IRBM, an integrated Contract Research Organization (CRO) specializing in preclinical drug discovery, has established a ...

Bacteria steal DNA from silent viruses and use it like a memory bank. That memory helps them protect future generations.

Using CRISPR-based engineering methods to prompt stem cells to organize into embryo-like structures, scientists were able to create 'programmable' cellular models of embryos without ever experimenting ...

CRISPR Therapeutics poised for growth with international potential and clinical assets. Read why I rate CRSP stock a Strong ...

Learn more about whether Alvotech or CRISPR Therapeutics AG is a better investment based on AAII's A+ Investor grades, which ...

Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics are part of the Zacks top Analyst Blog ...